The criteria for diagnosing binge-eating disorder have changed since the study was conducted, and Javaras notes that under the new guidelines, an even larger percentage of the study's participants ...

The study, published online ahead of press in the December 2024 edition of Psychiatry Research Communications, explores the subjective experiences of individuals with binge eating disorder and ...

The study, published online ahead of press in the December 2024 edition of Psychiatry Research Communications, explores the subjective experiences of individuals with binge eating disorder and ...

A growing number of people are struggling with their relationship with food in ways that don’t always meet the criteria for ...

Vyvanse isn't a new drug, but the FDA approved it as a treatment for binge eating disorder ... In one study, 255 people got different doses of either Vyvanse or a placebo with no medicine.

Rutgers Health researchers have uncovered mixed outcomes for patients using lisdexamfetamine, a stimulant commonly prescribed for binge eating disorder (BED). The study, led by Abanoub Armanious ...

Long overlooked in women 40 and older, midlife eating disorders are going up. Eating disorder specialists cite hormonal ...

Eating Disorder Treatment Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The binge-eating disorder treatment market is set to expand significantly, with an anticipated growth ...

In a 12-week study of 23 women with nonpurging bulimia, McCann and Agras reported that desipramine reduced binge eating by 63% compared with a 6% increase reported with placebo.

Doctors are already using weight loss drugs to treat binge eating disorder. But some experts warn that it’s a Band-Aid, not a fix. By Dani Blum Dani Blum has covered Ozempic and related ...